This table presents recent patent oppositions filed by Green Cross Corporation against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3626258Methods And Compositions For Cns Delivery Of Iduronate-2-SulfataseSHIRE HUMAN GENETIC THERAPIES, INC.May 3, 2022
EP3103469Cns Delivery Of Therapeutic AgentsSHIRE HUMAN GENETIC THERAPIES, INC.Sep 9, 2021